CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hanger, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hanger, Inc.
10910 Domain Drive
Suite 300
Phone: (512) 777-3800p:512 777-3800 Austin, TX  78758  United States Fax: (302) 636-5454f:302 636-5454
This company ceased filing statements with the SEC on 10/13/2022.
On 10/3/2022, the Company was acquired by Patient Square Capital.
This company is no longer actively traded on any major stock exchange.
Business Summary
Hanger, Inc. is a national provider of products and services that assist in enhancing or restoring the physical capabilities of patients with disabilities or injuries. The Company provides orthotic and prosthetic (O&P) services, distribute O&P devices and components, manage O&P networks, and provide therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings. It operates through two segments: Patient Care, and Products & Services. Its Patient Care segment is primarily comprised of Hanger Clinic, which specializes in comprehensive, outcomes-based design, fabrication, and delivery of custom O&P devices through approximately 760 patient care clinics and 115 satellite locations in 47 states and the District of Columbia. It also provides payor network contracting services to other O&P providers through this segment. Its Products & Services segment is comprised of its distribution services and therapeutic solutions businesses.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202212/31/2021YesYesYesYesYes

Industries
SIC Code Description
8093 Specialty outpatient facilities, not elsewhere classified
5047 Medical, dental, and hospital equipment and supplies
8322 Individual and family social services
3844 X-ray apparatus and tubes and related irradiation apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board Christopher B.Begley 69 1/1/2018 11/21/2013
President, Chief Executive Officer, Director Vinit K.Asar 56 5/21/2012 12/1/2008
Chief Financial Officer, Executive Vice President Thomas E.Kiraly 61 1/1/2015 10/1/2014
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SCOPe Orthotics & Prosthetics, Inc. 7720 Cardinal Court San Diego CA United States
ADVANCED PROSTHETICS OF AMER 2105 BLUE IRIS PL LONGWOOD FL
SUNCOAST ORTHOTIC AND PROSTHETIC 4050 NE 5TH AVE OAKLAND PARK FL US
14 additional Subsidiary records available in full report.

Business Names
Business Name
Accelerated Care Plus Corp.
Accelerated Care Plus Leasing, Inc.
Advanced Orthopro, Inc
59 additional Business Names available in full report.

General Information
Number of Employees: 5,200 (As of 12/31/2021)
Outstanding Shares: 39,123,266 (As of 8/3/2022)
Shareholders: 142
Stock Exchange: NYSE
Federal Tax Id: 840904275
Fax Number: (302) 636-5454
Email Address: Info@hanger.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 23, 2024